4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-000626
COO and SVP, R*D sold 20,512 shares at $17.00 ($348,640)
- COO and SVP, R*D acquired 20,512 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Johnston Lloyd P. · COO and SVP, R*D
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-15 | Exercise or conversion : show line 1 in the form | +20,512 | $0.47 | $9,641 | 22,118 | D |
| 2017-06-15 | Sale : show line 2 in the form | −20,512 | $17.00 | $348,640 | 1,606 | D |
| Open-market sales · 20,512 sh · avg $17.00 · $348,640 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2017-06-15 | Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) | −20,512 | $0.47 | 2019-07-23 | 20,512 | 0 | D |
Loading xslF345X03/doc4_4803.xml…